Yana Najjar

Yana Najjar

Oncology

5150 Centre Ave
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.

Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.

Journal: Oncoimmunology

Published: June 22, 2026

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report.

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report.

Journal: Frontiers in immunology

Published: April 24, 2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Journal: Cancers

Published: November 27, 2025

Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.

Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma.

Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Updates on intratumoral therapies in melanoma.

Updates on intratumoral therapies in melanoma.

Journal: Cancer

Published: October 26, 2025

Functional and Proteomic Profiles of CD3(+) Plasma-Derived Small Extracellular Vesicles Differentiate Cancer Patients From Healthy Donors.

Functional and Proteomic Profiles of CD3(+) Plasma-Derived Small Extracellular Vesicles Differentiate Cancer Patients From Healthy Donors.

Journal: European journal of immunology

Published: October 14, 2025

Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.

Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.

Journal: Neurosurgery

Published: August 29, 2025

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.

Journal: EClinicalMedicine

Published: May 14, 2025

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

Journal: Journal for immunotherapy of cancer

Published: February 05, 2025

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.

Journal: Journal for immunotherapy of cancer

Published: January 21, 2025

Assessment of adenosinergic activity of small extracellular vesicles in plasma of cancer patients and healthy donors.

Assessment of adenosinergic activity of small extracellular vesicles in plasma of cancer patients and healthy donors.

Journal: Oncoimmunology

Published: December 20, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026